Semnur Pharmaceuticals Inc SMNR
Trading Information
- Previous Close Price
- $0.42
- Day Range
- $0.29–0.56
- 52-Week Range
- $0.13–23.00
- Bid/Ask
- $0.40 / $0.54
- Shares Outstanding
- 230.21M
- Market Cap
- $124.31M
- Volume/Avg
- 13,187 / 7,653
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Semnur Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its main product candidate, SP-102 (10 mg, dexamethasone sodium phosphate viscous gel), is being developed as a non-opioid novel injectable corticosteroid gel formulation for patients with moderate to severe LRP (also known as sciatica), containing no preservatives, surfactants, solvents, or particulates.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 10
- Website
- https://www.semnurpharma.com
Valuation
|
Metric
|
SMNR
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
SMNR
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.11 |
Interest Coverage | — |
Quick Ratio
SMNR
Profitability
|
Metric
|
SMNR
|
|---|---|
Return on Assets (Normalized) | −750.18% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
SMNR
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|tS^Hx<% | LOCK|&kY! | $129B | |||
| Moderna Inc
MRNA
| LOCK|>^%yFL& | LOCK|gV | $90B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|@lnP>xT | LOCK|xzkp@ | $77B | |||
| argenx SE ADR
ARGX
| LOCK|<!T^#k | LOCK|$@ | $51B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|VMb<^Q | LOCK|tR | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|$%C#bwJ | LOCK|TVq< | $31B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|>#qw$&& | LOCK|J@$p | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|mSWXZkr | LOCK|JX? | $24B | |||
| Incyte Corp
INCY
| LOCK|hBGfJlW | LOCK|!<@ | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|?K&rvn? | LOCK|fdV | $14B |
United States